Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term long-term survival. Found 13 abstracts

Shaikh T, Meyer JE, Horwitz EM. Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer. Surg Oncol Clin N Am. 2017 Jul;26(3):405-29.   PMCID: REVIEW
Kulke MH, Benson AB, Bergsland E, Berlin JD, Blaszkowsky LS, Choti MA, Clark OH, Doherty GM, Eason J, Emerson L, Engstrom PF, Goldner WS, Heslin MJ, Kandeel F, Kunz PL, Kuvshinoff BW, Moley JF, Pillarisetty VG, Saltz L, Schteingart DE, Shah MH, Shibata S, Strosberg JR, Vauthey JN, White R, Yao JC, Freedman-Cass DA, Dwyer MA. Neuroendocrine Tumors Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2012 Jun;10(6):724-64.   PMCID: not NIH funded
Mejia A, Schulz S, Hyslop T, Weinberg DS, Waldman SA. Molecular staging individualizing cancer management. Journal of surgical oncology. 2012 Apr;105(5):468-74.   PMCID: PMC3312802
Shindoh J, Loyer EM, Kopetz S, Boonsirikamchai P, Maru DM, Chun YS, Zimmitti G, Curley SA, Charnsangavej C, Aloia TA, Vauthey JN. Optimal Morphologic Response to Preoperative Chemotherapy: An Alternate Outcome End Point Before Resection of Hepatic Colorectal Metastases. Journal of Clinical Oncology. 2012 Dec;30(36):4566-72.   PMCID: PMC3518730
Elkin EB, Klem ML, Gonzales AM, Ishill NM, Hodgson D, Ng AK, Marks LB, Weidhaas J, Freedman GM, Miller RC, Constine LS, Myrehaug S, Yahalom J. Characteristics and Outcomes of Breast Cancer in Women With and Without a History of Radiation for Hodgkin's Lymphoma: A Multi-Institutional, Matched Cohort Study. Journal of Clinical Oncology. 2011 Jun;29(18):2466-73.   PMCID: PMC3138631[Available on 2012/6/20]
Fogh SE, Yu A, Kubicek GJ, Scott W, Mitchell E, Rosato EL, Berger AC. DO ELDERLY PATIENTS EXPERIENCE INCREASED PERIOPERATIVE OR POSTOPERATIVE MORBIDITY OR MORTALITY WHEN GIVEN NEOADJUVANT CHEMORADIATION BEFORE ESOPHAGECTOMY?. International Journal of Radiation Oncology Biology Physics. 2011 Aug;80(5):1372-6.   PMCID: not NIH funded
Tempero MA, Arnoletti JP, Behrman S, Ben-Josef E, Benson AB, Berlin JD, Cameron JL, Casper ES, Cohen SJ, Duff M, Ellenhorn JD, Hawkins WG, Hoffman JP, Kuvshinoff BW, Malafa MP, Muscarella P, Nakakura EK, Sasson AR, Thayer SP, Tyler DS. Pancreatic Adenocarcinoma. Journal of the National Comprehensive Cancer Network. 2010 Sep;8(9):972-+.   PMCID: PMC3135380
Touijer K, Jacqmin D, Kavoussi LR, Montorsi F, Patard JJ, Rogers CG, Russo P, Uzzo RG, Van Poppel H. The Expanding Role of Partial Nephrectomy: A Critical Analysis of Indications, Results, and Complications. European Urology. 2010 Feb;57(2):214-22.   PMCID: not NIH funded
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. Colon Cancer. Journal of the National Comprehensive Cancer Network. 2009 Sep;7(8):778-831.   PMCID: no NIH - Practice Guideline
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. Rectal Cancer. Journal of the National Comprehensive Cancer Network. 2009 Sep;7(8):838-81.   PMCID: not NIH funded
Langer CJ, Mehta MP. Current management of brain metastases, with a focus on systemic options. Journal of Clinical Oncology. 2005 Sep;23(25):6207-19.
Hoffman JP, Lipsitz S, Pisansky T, Weese JL, Solin L, Benson AB. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An eastern cooperative oncology group study. Journal of Clinical Oncology. 1998 Jan;16(1):317-23.
Langer CJ, Rosenblum N, Hogan M, Nash S, Bagchi P, Lacreta FP, Catalano R, Comis RL, Odwyer PJ. Intraperitoneal Cisplatin and Etoposide in Peritoneal Mesothelioma - Favorable Outcome with a Multimodality Approach. Cancer Chemotherapy and Pharmacology. 1993 Jun;32(3):204-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term long-term survival

long-term survival cancer surgery NCCN Clinical Practice Guidelines phase-iii trial prospective randomized-trial pathological complete response chemotherapy adenocarcinoma oxaliplatin chemoradiotherapy irinotecan radiation-therapy chemoradiation neoplasm recurrence neoplasm staging adjuvant chemotherapy prognostic-factors squamous-cell carcinoma colorectal pathological response quantitative reverse guanylyl cyclase-c metastatic colorectal-cancer ductal carcinoma randomized controlled-trial multimodal therapy endoscopic retrograde randomized phase-iii cell lung-cancer Renal cell carcinoma in-hospital mortality oncological outcomes islet-cell carcinoma total mesorectal excision lymph-node metastases colorectal cancer colonic neoplasms Esophagectomy dose rate malignant mesothelioma motexafin gadolinium gemcitabine controlled-trial 2nd cancer complications transcriptase-polymerase chain reaction growth-factor receptor cooperative-oncology-group phase-ii combination Radiation therapy fluorouracil plus leucovorin prognostic scoring system age surrogate end-points zd1839 iressa metastatic disease prognostic markers adrenal-cortical carcinoma Renal tumours 2011 mmier rf-j clin oncol s-v29-p4103 radical nephrectomy laparoscopic partial recurrence computed-tomography esophageal cancer lymph-node micrometastases 3-dimensional conformal radiotherapy therapy-oncology-group Partial nephrectomy Elderly intensity-modulated radiotherapy neoadjuvant chemotherapy lymph nodes guanylyl cyclase C resected high-grade dysplasia lymph-node evaluation unresectable liver metastases extended retroperitoneal lymphadenectomy bevacizumab ionizing-radiation endocrine resection treatment strategy sporadic esophagectomy breast renal-cell carcinoma staging surgical adjuvant radiotherapy ii colon-cancer ultrasonography nephrectomy portal-vein confluence disease pancreas colorectal liver metastases preoperative biliary drainage positive surgical margins gene-expression profiles 5-fluorouracil randomized 1987 arlson me-v40-p373 escherichia-coli rectal neoplasms fluorouracil trimodality NCCN Guidelines predictive markers neoadjuvant chemoradiotherapy liver-transplantation cholangiopancreatography ductal adenocarcinoma risk-factors radiolabeled somatostatin analog oxaliplatin-based proposed staging system hepatic arterial chemoembolization circumferential resection margin pancreaticoduodenectomy normal contralateral kidney iii childhood colorectal-carcinoma high-dose Chemotherapy adrenocortical tumors Neoadjuvant therapy gastroesophageal junction stereotactic radiosurgery colon-cancer female survivors mortality GUCY2C 1987 ang a-radiology-v163-p123 10-year follow-up liver metastases leucovorin thiosulfate nephron-sparing surgery 4 cm head heat-stable enterotoxin Nephron-sparing surgery imrt adjuvant radiotherapy esophagus
Last updated on Wednesday, February 05, 2020